Elucidating the Molecular Markers and Mechanistic Pathways Associated with Sarcopenia Risk in Patients Undergoing Metabolic Bariatric Surgery

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250708003

Enrollment

138

Registered

2025-07-08

Start date

2025-08-11

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia obesity metabolic bariatric surgery Sarcopenia obesity metabolic bariatric surgery

Interventions

This is a prospective, observational cohort study comprise of 138 patients undergoing metabolic bariatric surgery

Basic Science

group 1

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria of this study are: Patients undergoing elective metabolic bariatric surgery as listed in 3.1 18 to 65 years old

Exclusion criteria

Exclusion criteria: Pregnant History of previous bariatric surgery/ procedure Patients with underlying IHD, CKD stage IIIB and above, hypothyroidism Patients develop post-surgical complications/ infection Patients who have active infection/ inflammation (e.g. urti, ssi) in a period of one week before taking blood.

Design outcomes

Primary

Measure	Time frame
Identification of inflammatory markers 3 months post metabolic bariatric surgery il-1, il-6, tnf alpha, hs crp	—

Secondary

Measure	Time frame
proteins 3 months post metabolic bariatric surgery plasma	—

Countries

Malaysia

Contacts

Public ContactSOLOMON RAJ VASUDAYAN

NATIONAL UNIVERSITY OF MALAYSIA

solomonrv94@gmail.com0198818742

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026